Home › Funds › Meridiem Capital Partners LP › THC

Meridiem Capital Partners LP position in THC

TENET HEALTHCARE CORP · Health Care

Meridiem Capital Partners LP reported holding 226,542 shares of THC (TENET HEALTHCARE CORP) in its Q2 2026 13F filing — a position valued at US$42.4M, representing 1.96% of its reported portfolio and ranking #14 among its reported holdings. Meridiem Capital Partners LP has disclosed THC holdings in 4 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)226.54K sh
Reported value held$42.38M
Portfolio Weight1.96%
First reportedQ4 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Meridiem Capital Partners LP's THC position evolved

Meridiem Capital Partners LP first disclosed a stake in THC in Q4 2024 at 23,427 shares (US$3.0M). The position peaked in Q2 2026 at 226,542 shares, worth US$42.4M. Across 4 filings, Meridiem Capital Partners LP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 226,542 shares valued at US$42.4M — an increase of 46,059 shares quarter over quarter.. Notable position changes include a 598% increase in Q1 2026 (shares were roughly flat over the following quarter), a 26% increase in Q2 2026 (shares rose 37% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 23.43K $2.96M New
Q4 2025 25.85K $5.14M New
Q1 2026 180.48K $34.06M Add
Q2 2026 226.54K $42.38M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About THC and 13F data

THC (TENET HEALTHCARE CORP) is a Health Care company. 40 other funds we track also report a position in THC — the largest reported positions include Boston Partners (US$829.1M), GLENVIEW CAPITAL MANAGEMENT, LLC (US$418.2M), MANNING & NAPIER ADVISORS LLC (US$168.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding THC

All THC fund holders →

FAQ

How long has Meridiem Capital Partners LP held THC?

Meridiem Capital Partners LP has disclosed THC holdings in 4 of the last 7 reported quarters, going back to Q4 2024.

What is Meridiem Capital Partners LP's current position in THC?

As of Q2 2026, Meridiem Capital Partners LP holds 226.54K shares of THC (TENET HEALTHCARE CORP), valued at $42.38M, representing 1.96% of its reported portfolio and ranking #14.

Has Meridiem Capital Partners LP been buying or selling THC?

In the latest 13F filing (Q2 2026), Meridiem Capital Partners LP increased its position in THC. The position peaked in Q2 2026 at 226.54K shares.

Which other funds hold THC?

Other major institutional holders of THC include Boston Partners, GLENVIEW CAPITAL MANAGEMENT, LLC, MANNING & NAPIER ADVISORS LLC, among 40 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.